Oral vaccination and protection of red foxes ( Vulpes vulpes ) against rabies using ONRAB® , an adenovirus-rabies recombinant vaccine

Oral vaccination and protection of red foxes ( Vulpes vulpes ) against rabies using ONRAB® , an adenovirus-rabies recombinant vaccine

Highlights • 79% (11/14) of adult foxes responded to vaccination with ONRAB® oral rabies vaccine. • 46% (6/13) of juveniles responded to vaccination with ONRAB®. • Best time to sample wild fox sera for evidence of vaccination is 7–11 weeks post-ORV. • 80% (8/10) of adults considered responders to va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2014-02, Vol.32 (8), p.984-989
Hauptverfasser: Brown, L.J, Rosatte, R.C, Fehlner-Gardiner, C, Bachmann, P, Ellison, J.A, Jackson, F.R, Taylor, J.S, Davies, C, Donovan, D
Format: Artikel
Sprache:eng
Schlagworte:
Adenoviridae
Administration, Oral
Allergy and Immunology
Animals
Antibodies, Neutralizing - blood
Antibodies, Viral - blood
Applied microbiology
Baits
Biological and medical sciences
Disease control
Foxes
Foxes - immunology
Fundamental and applied biological sciences. Psychology
Human adenovirus serotype 5
Immune response
Immunity, Humoral
Microbiology
Miscellaneous
ONRAB
Oral rabies vaccination
Rabies
Rabies - prevention & control
Rabies control
Rabies Vaccines - administration & dosage
Rabies virus challenge
Red fox
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Vaccines, Synthetic - administration & dosage
Virology
Vulpes vulpes
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • 79% (11/14) of adult foxes responded to vaccination with ONRAB® oral rabies vaccine. • 46% (6/13) of juveniles responded to vaccination with ONRAB®. • Best time to sample wild fox sera for evidence of vaccination is 7–11 weeks post-ORV. • 80% (8/10) of adults considered responders to vaccination survived rabies challenge. • 67% (4/6) of juvenile foxes considered responders to vaccination survived challenge.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.12.015